Company Announcements

WORLDWIDE HEALTHCARE TRUST PLC

Results of the Annual General Meeting

The following resolutions were passed by shareholders on a poll at the Annual General Meeting of the Company held on Wednesday, 10 July 2024. The level of votes received is shown below.

Resolutions                 Votes For   %       Votes      %      Total Votes Votes
                                                Against           Cast        Withheld*

Ordinary Resolutions

  1. To receive and
     consider the audited
     accounts and the       255,457,442 99.99%  14,302     0.01%  255,471,744 30,607
     Report of the
     Directors for the year
     ended 31 March 2024.
  1. To approve the payment
     of a final dividend of 255,486,386 100.00% 5,935      0.00%  255,492,321 10,030
     2.1p per ordinary
     share for the year
     ended 31 March 2024.
  1. To approve the
     Company's dividend
     policy as set out on   255,455,553 99.99%  16,695     0.01%  255,472,248 30,103
     page 31 of the Annual
     Report for the year
     ended 31 March 2024.
  1. To re-elect Mr Doug
     McCutcheon as a        181,346,792 74.64%  61,627,965 25.36% 242,974,757 12,525,670
     Director of the
     Company.
  1. To re-elect Mr Sven    186,829,542 73.14%  68,597,201 26.86% 255,426,743 73,684
     Borho as a Director of
     the Company.
  1. To re-elect Dr Bina    216,903,447 99.97%  72,255     0.03%  216,975,702 38,524,725
     Rawal as a Director of
     the Company.
  1. To re-elect Mr Tim     255,351,714 99.97%  73,525     0.03%  255,425,239 75,188
     Livett as a Director
     of the Company.
  1. To re-elect Ms Jo      255,364,786 99.97%  71,580     0.03%  255,436,366 64,061
     Parfrey as a Director
     of the Company.
  1. To re-appoint
     PricewaterhouseCoopers
     LLP as auditor and to  255,286,968 99.96%  108,668    0.04%  255,395,636 106,715
     authorise the Audit
     Committee to determine
     their remuneration.
  1. To approve the
     Directors'             242,950,834 95.12%  12,452,604 4.88%  255,403,438 98,913
     Remuneration Report
     for the year ended 31
     March 2024.
  1. To authorise the
     Directors to allot     255,337,066 99.96%  99,743     0.04%  255,436,809 64,200
     securities in the
     Company.
Special Resolutions

  1. To disapply the rights
     of pre -emption in     241,111,828 94.39%  14,338,921 5.61%  255,450,749 51,602
     relation to the
     allotment of
     securities.
  1. To sell relevant
     shares for cash as if,
     immediately before the 241,143,152 94.40%  14,313,007 5.60%  255,456,159 46,192
     sale such shares are
     held by the Company as
     treasury shares.
  1. To authorise the
     Company to make market 250,007,061 97.85%  5,482,191  2.15%  255,489,252 13,099
     purchases of shares in
     the Company.
  1. That any General
     Meeting of the Company
     (other than the Annual 254,995,231 99.81%  487,090    0.19%  255,482,321 20,030
     General Meeting) shall
     be called by notice of
     at least 14 clear
     days.
Ordinary Resolution

  1. To approve the
     continuance of the
     Company as an          239,326,975 93.67%  16,171,746 6.33%  255,498,721 3,630
     investment trust for a
     further period of five
     years.

* Please note that `Vote withheld' is not a vote in law and is not counted in the calculation of the proportion of votes `For' and `Against `a resolution.

Any proxy votes which are at the discretion of the Chair of the Meeting have been included in the "for" total. A vote withheld is not a vote in law and is not counted in the calculations of votes cast by proxy.

At the date of the AGM the total number of Ordinary shares of 2.5p each in issue was 528,677,044 (with 72,988,156 shares held in treasury). The total number of voting rights was 528,677,044.

The voting figures will shortly also be available on the Company's website at www.worldwidewh.com

All of the resolutions proposed at the Annual General Meeting (AGM) were passed. The majority of resolutions passed with votes in favour in excess of 93%. The votes in favour of Resolution 4 to re-elect Doug McCutcheon and Resolution 5 to re-elect Sven Borho as directors of the Company, were 74.6% and 73.1% in favour respectively.

Where 20% or more of votes have been cast against any shareholder resolution, the Company is required by provision 4 of the UK Corporate Governance Code to explain what action it will take to consult shareholders to understand the reasons behind the result.

Mr McCutcheon, as Chair of the Board, together with Mr Borho and Dr Bina Rawal, the Company's Senior Independent Director, met with the Company's principal shareholders in advance of the AGM. The Board understands that some shareholders deem Mr McCutcheon to no longer be independent, due to his length of service (11 years) on the Board, and Mr Borho to not be independent, due to his role as a Managing Partner at OrbiMed Capital LLC, the Company's Portfolio Manager.

As stated in this year's Annual Report, Mr McCutcheon was asked by the Board to take on the role of Board Chair from July 2022 for a period of three to five years. This was to oversee the renewal of the Board and ensure an orderly succession process. Since then, all but one of the Board's Independent Directors have retired and the composition and leadership of the Board's Committees has been changed. In the upcoming financial year, the Company expects to add another new Independent Director, to replace Humphrey van der Klugt, who retired at this year's AGM. In the light of the good progress made, Mr McCutcheon is not expected to serve as Chair of the Company beyond the Company's 2026 AGM.

Mr Borho was appointed a Director of the Company in June 2018. The Board believes that the Company continues to benefit from his extensive knowledge and experience in investment matters. Mr Borho is the only Director deemed not to be independent by the Board. The Board has also taken steps to avoid any potential conflicts of interest, Mr Borho does not sit on any of the Board's Committees and he does not receive a fee for serving as a Director.

The Company will continue to engage with shareholders on these and other matters.

In accordance with Listing Rule 9.6.2, the full text of the special business resolution passed has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/ nationalstoragemechanism . Resolutions 1 to 16 will additionally be filed at Companies House.

10 July 2024

For further information please contact:

Mark Pope        Frostrow Capital LLP - Company Secretary        020 3 008 4913